Tocilizumab in the Treatment of Juvenile Rheumatoid Arthritis

Journal Title: Здоров`я дитини - Year 2015, Vol 2, Issue 61

Abstract

In the development of rheumatic diseases, especially juvenile rheumatoid arthritis, the important role of some cytokines, most important of which are interleukin-1, interleukin-6 and tumor necrosis factor α, has been proved. A step forward in the treatment of this group of diseases is immunobiological products. The preparation of humanized anti-interleukin-6 receptor antibodies tocilizumab is highly effective and safe agent for the treatment of systemic and polyarticular forms of juvenile rheumatoid arthritis.

Authors and Affiliations

V. V. Berejniy, T. V. Marushko, O. B. German, Ye. Yu. Marushko

Keywords

Related Articles

Additional Medical Support of Antibiotic Therapy: the Need or Polypharmacy? Part 1. Probiotics

The paper presents an analysis of the results of current researches on the need, effectiveness and safety of additional pharmacological prevention for adverse events associated with the use of antibiotics in children. Th...

Interrelations of impaired biochemical and immunological homeostasis in patients with juvenile rheumatoid arthritis taking into account the disease duration

Background. Juvenile rheumatoid arthritis (JRA) is a life-long pathological condition. Therefore, the study of the mechanisms of its development, the metabolic systems functioning, the formation of dystrophic changes on...

Modern Approaches to the Diagnosis and Treatment of Tonsillopharyngitis (Review of International Guidelines)

The article presents an overview of guidelines on the treatment of tonsillopharyngitis in children. Attention is given to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in this pathology. It is emphasized that...

Atopic march in pediatrics: genotype-associated mechanisms Part 2. Perspective genotype-associated mechanisms and markers of atopic disorders in children

The review deals with the data of studies covering last 10 years held in populations of different countries concerning the association of atopic diseases, which compose the atopic march in children (atopic eczema, allerg...

Correlation between serum content of cytokines and neuropeptides in children with recurrent bronchitis and vertebrobasilar arterial system syndrome

Background. The presence of nervous regulation imbalance in children is a cause of bronchopulmonary pathology with severe clinical course. The study of neuroimmune relationships in children with vertebrobasilar arterial...

Download PDF file
  • EP ID EP229924
  • DOI -
  • Views 52
  • Downloads 0

How To Cite

V. V. Berejniy, T. V. Marushko, O. B. German, Ye. Yu. Marushko (2015). Tocilizumab in the Treatment of Juvenile Rheumatoid Arthritis. Здоров`я дитини, 2(61), 151-157. https://europub.co.uk/articles/-A-229924